tradingkey.logo

IQVIA Holdings Inc

IQV
View Detailed Chart
217.830USD
-0.300-0.14%
Close 10/29, 16:00ETQuotes delayed by 15 min
37.03BMarket Cap
29.94P/E TTM

IQVIA Holdings Inc

217.830
-0.300-0.14%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.14%

5 Days

-0.01%

1 Month

+20.53%

6 Months

+41.96%

Year to Date

+10.85%

1 Year

+0.69%

View Detailed Chart

TradingKey Stock Score of IQVIA Holdings Inc

Currency: USD Updated: 2025-10-29

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

IQVIA Holdings Inc's Score

Industry at a Glance

Industry Ranking
3 / 407
Overall Ranking
24 / 4623
Industry
Biotechnology & Medical Research

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 25 analysts
Buy
Current Rating
241.321
Target Price
+10.63%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

IQVIA Holdings Inc Highlights

StrengthsRisks
IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 15.40B.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 15.40B.
Overvalued
The company’s latest PE is 31.29, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 175.08M shares, decreasing 0.69% quarter-over-quarter.
Held by David G. Herro
Star Investor David G. Herro holds 11.75M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.10.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

IQVIA Holdings Inc Info

IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.
Ticker SymbolIQV
CompanyIQVIA Holdings Inc
CEOMr. Ari Bousbib
Websitehttps://ir.iqvia.com/
KeyAI